Is It Time to Dump Your Shares of Tilray?​

Core Viewpoint - Tilray Brands has experienced significant stock declines, with a 16% drop over the past year, 74% over the past three years, and 97% over the past five years, raising concerns about its future growth potential and investment viability [1]. Group 1: Company Background - Tilray was an early mover in the cannabis legalization market in North America, aiming for rapid growth through partnerships and acquisitions after going public [2]. - The company is now one of the largest cannabis firms globally, reporting annual sales exceeding $837 million, with a product range that includes cannabis flower, beverages, and medicinal products [3]. Group 2: Financial Performance and Challenges - Despite its growth, Tilray has consistently burned cash and has not executed its business strategy effectively, facing challenges from illicit markets that pressure pricing and profit margins [4]. - The company has significantly diluted its shares, with a 495% increase in share count since its U.S. market debut in July 2018, contributing to poor stock performance [5]. Group 3: Future Outlook - Tilray's total net revenue grew by only 3% in Q2 of fiscal year 2026, with Wall Street projecting low-to-mid single-digit growth through the end of the next fiscal year, indicating limited growth potential [6]. - Given the substantial decline in stock value, there are sentiments that holding or buying more Tilray shares may not be prudent, suggesting that it may be better to divest until the company demonstrates improved performance [7].